Stocktoria
ARS Pharmaceuticals, Inc. SPRY
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2020-12-04
Chart by TradingView
2/9
Piotroski F — financial health
-1.13
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $84.3M | $89.1M | $30,000 | $1.3M | $5.5M |
| Operating income | -$179.4M | -$3.1M | -$67.5M | -$35.5M | -$19.5M |
| Net income | -$171.3M | $8.0M | -$54.4M | -$34.7M | -$20.2M |
| Operating cash flow | -$170.9M | $13.5M | -$59.3M | -$40.1M | -$17.6M |
| Free cash flow | -$171.2M | $13.0M | -$59.4M | -$40.3M | -$17.6M |
| Total assets | $327.7M | $351.2M | $233.2M | $281.4M | $61.4M |
| Total liabilities | $213.4M | $94.4M | $2.4M | $8.5M | $16.7M |
| Shareholders' equity | $114.3M | $256.8M | $230.8M | $272.9M | -$31.3M |
| Ratios | |||||
| Operating margin | -212.9% | -3.5% | -225066.7% | -2698.8% | -353.3% |
| Net margin | -203.3% | 9.0% | -181216.7% | -2635.4% | -367.7% |
| FCF margin | -203.1% | 14.6% | -198136.7% | -3060.6% | -319.9% |
| Return on assets | -52.3% | 2.3% | -23.3% | -12.3% | -32.9% |
| Return on equity | -149.9% | 3.1% | -23.6% | -12.7% | 64.7% |
| Debt / equity | 0.84× | 0.00× | — | — | — |
| Current ratio | 7.28 | 14.26 | 96.92 | 51.01 | 7.42 |
| Revenue growth | -5.5% | 297063.3% | -97.7% | -76.1% | — |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| Third Point LLC | 1,000,000 | $8.0M |
Why these scores methodology →
Piotroski F-score: 2/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -1.13 (distress)
- Working capital / assets 0.75
- Retained earnings / assets -0.899
- EBIT / assets -0.548
- Equity / liabilities 0.535
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001671858 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.